Recalls / Class II
Class IID-1098-2019
Product
PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .
- Affected lot / code info
- Lot:(a) 26092018@22, 26092018@22, 09102018@47, 15102018@33, 15102018@33, 09102018@47, 15102018@33, 09102018@47, 29112018@4, 10122018@14, 29112018@4, 29112018@4, 19122018@20, 21122018@29, 21122018@29, 27122018@20, (b) 16012019@59, 18012019@17, 21012019@49, 21012019@49, 22012019@24, 22012019@24, distributed between 09-01-2018 to 02-20-2019.
Why it was recalled
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recalling firm
- Firm
- Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
- Notification channel
- Telephone
- Type
- Voluntary: Firm initiated
- Address
- 996 Nw Circle Blvd Ste 105, N/A, Corvallis, Oregon 97330-1485
Distribution
- Quantity
- 25 prescriptions 10, 9, ml injectable
- Distribution pattern
- Dispensed in Oregon
Timeline
- Recall initiated
- 2019-02-21
- FDA classified
- 2019-04-09
- Posted by FDA
- 2019-04-17
- Terminated
- 2020-07-23
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1098-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.